Robeco Institutional Asset Management
ARCT icon

Robeco Institutional Asset Management’s Arcturus Therapeutics ARCT Stock Holding History

Robeco Institutional Asset Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,842
Closed -$288K – 908
2024
Q2 		$288K Sell
11,842
-102
-0.9% -$3.09K ﹤0.01% 878
2024
Q1 		$403K Hold
11,944
– – ﹤0.01% 857
2023
Q4 		$377K Buy
11,944
+102
+0.9% +$2.42K ﹤0.01% 863
2023
Q3 		$303K Buy
+11,842
New +$365K ﹤0.01% 888

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Robeco Institutional Asset Management's ARCT Position: Q3 2024 in Review

Robeco Institutional Asset Management sold out of Arcturus Therapeutics (ARCT) in Q3 2024, closing a stake of 11,842 shares — an estimated $288K sold.

Robeco Institutional Asset Management first reported a position in ARCT in Q3 2023 and held it in 4 quarters. The position peaked at $403K in Q1 2024. 164 funds tracked by Wall St. Rank hold ARCT as of Q3 2024.

  • Robeco Institutional Asset Management reported no remaining Arcturus Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 11,842 Arcturus Therapeutics shares in Q3 2024, an estimated $288K.
  • Robeco Institutional Asset Management first reported a position in Arcturus Therapeutics in Q3 2023 and held it in 4 quarters.
  • Robeco Institutional Asset Management's Arcturus Therapeutics position peaked at $403K in Q1 2024.
  • 164 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2024.

Based on Robeco Institutional Asset Management's 13F filing for Q3 2024, filed 29 Oct 2024.